212 related articles for article (PubMed ID: 16757484)
1. High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa.
Bajaj SP; Schmidt AE; Agah S; Bajaj MS; Padmanabhan K
J Biol Chem; 2006 Aug; 281(34):24873-88. PubMed ID: 16757484
[TBL] [Abstract][Full Text] [Related]
2. Structural biology of factor VIIa/tissue factor initiated coagulation.
Vadivel K; Bajaj SP
Front Biosci (Landmark Ed); 2012 Jun; 17(7):2476-94. PubMed ID: 22652793
[TBL] [Abstract][Full Text] [Related]
3. Structure of human factor VIIa-soluble tissue factor with calcium, magnesium and rubidium.
Vadivel K; Schmidt AE; Cascio D; Padmanabhan K; Krishnaswamy S; Brandstetter H; Bajaj SP
Acta Crystallogr D Struct Biol; 2021 Jun; 77(Pt 6):809-819. PubMed ID: 34076594
[TBL] [Abstract][Full Text] [Related]
4. Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X.
Neuenschwander PF; Morrissey JH
J Biol Chem; 1994 Mar; 269(11):8007-13. PubMed ID: 8132522
[TBL] [Abstract][Full Text] [Related]
5. Site-directed fluorescence probing to dissect the calcium-dependent association between soluble tissue factor and factor VIIa domains.
Carlsson K; Osterlund M; Persson E; Freskgård PO; Carlsson U; Svensson M
Biochim Biophys Acta; 2003 May; 1648(1-2):12-6. PubMed ID: 12758142
[TBL] [Abstract][Full Text] [Related]
6. Spectroscopic probing of the influence of calcium and the gla domain on the interaction between the first EGF domain in factor VIIa and tissue factor.
Osterlund M; Owenius R; Persson E; Lindgren M; Carlsson U; Freskgård PO; Svensson M
Eur J Biochem; 2000 Oct; 267(20):6204-11. PubMed ID: 11012674
[TBL] [Abstract][Full Text] [Related]
7. Binding of Zn2+ to a Ca2+ loop allosterically attenuates the activity of factor VIIa and reduces its affinity for tissue factor.
Petersen LC; Olsen OH; Nielsen LS; Freskgård PO; Persson E
Protein Sci; 2000 May; 9(5):859-66. PubMed ID: 10850795
[TBL] [Abstract][Full Text] [Related]
8. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.
Thiec F; Cherel G; Christophe OD
J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356
[TBL] [Abstract][Full Text] [Related]
9. Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitution in factor IX.
Ndonwi M; Broze GJ; Agah S; Schmidt AE; Bajaj SP
J Biol Chem; 2007 May; 282(21):15632-44. PubMed ID: 17387172
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the interaction between the light chain of factor VIIa and tissue factor.
Persson E
FEBS Lett; 1997 Aug; 413(2):359-63. PubMed ID: 9280313
[TBL] [Abstract][Full Text] [Related]
11. The length of the linker between the epidermal growth factor-like domains in factor VIIa is critical for a productive interaction with tissue factor.
Persson E; Madsen JJ; Olsen OH
Protein Sci; 2014 Dec; 23(12):1717-27. PubMed ID: 25234571
[TBL] [Abstract][Full Text] [Related]
12. Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy.
Freskgård PO; Olsen OH; Persson E
Protein Sci; 1996 Aug; 5(8):1531-40. PubMed ID: 8844844
[TBL] [Abstract][Full Text] [Related]
13. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
Kemball-Cook G; Johnson DJ; Tuddenham EG; Harlos K
J Struct Biol; 1999 Oct; 127(3):213-23. PubMed ID: 10544046
[TBL] [Abstract][Full Text] [Related]
15. Sequential coagulation factor VIIa domain binding to tissue factor.
Osterlund M; Persson E; Carlsson U; Freskgård PO; Svensson M
Biochem Biophys Res Commun; 2005 Dec; 337(4):1276-82. PubMed ID: 16236263
[TBL] [Abstract][Full Text] [Related]
16. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
Persson E; Olsen OH
FEBS J; 2009 Jun; 276(11):3099-109. PubMed ID: 19490111
[TBL] [Abstract][Full Text] [Related]
17. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
Carlsson K; Persson E; Carlsson U; Svensson M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1111-6. PubMed ID: 16970919
[TBL] [Abstract][Full Text] [Related]
19. The solution structure of human coagulation factor VIIa in its complex with tissue factor is similar to free factor VIIa: a study of a heterodimeric receptor-ligand complex by X-ray and neutron scattering and computational modeling.
Ashton AW; Boehm MK; Johnson DJ; Kemball-Cook G; Perkins SJ
Biochemistry; 1998 Jun; 37(22):8208-17. PubMed ID: 9609717
[TBL] [Abstract][Full Text] [Related]
20. A selective, slow binding inhibitor of factor VIIa binds to a nonstandard active site conformation and attenuates thrombus formation in vivo.
Olivero AG; Eigenbrot C; Goldsmith R; Robarge K; Artis DR; Flygare J; Rawson T; Sutherlin DP; Kadkhodayan S; Beresini M; Elliott LO; DeGuzman GG; Banner DW; Ultsch M; Marzec U; Hanson SR; Refino C; Bunting S; Kirchhofer D
J Biol Chem; 2005 Mar; 280(10):9160-9. PubMed ID: 15632123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
